1. ScholarBank@NUS

Wan-Teck Darren Lim

rp07954

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Wan-Teck Darren Lim
Variants
Lim, W.-T.
 
Main Affiliation
 
Faculty
 
Email
gmslwtd@nus.edu.sg
 

Publications

Refined By:
Department:  DEAN'S OFFICE (DUKE-NUS MEDICAL SCHOOL)
Policy:  Open
Author:  Tan, Eng Huat
Date Issued:  2018

Results 1-4 of 4 (Search time: 0.003 seconds).

Issue DateTitleAuthor(s)
12018Elucidating the genomic architecture of Asian EGFR-mutant lung adenocarcinoma through multi-region exome sequencingNahar, R; Zhai, W; Zhang, T; Takano, A; Khng, A.J; Lee, Y.Y; Liu, X; Lim, C.H; Koh, T.P.T; Aung, Z.W; Lim, T.K.H ; Veeravalli, L; Yuan, J; Teo, A.S.M; Chan, C.X; Poh, H.M; Chua, I.M.L; Liew, A.A; Lau, D.P.X; Kwang, X.L; Toh, C.K; Lim, W.-T ; Lim, B; Tam, W.L ; Tan, E.-H ; Hillmer, A.M; Tan, D.S.W
23-Dec-2018Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastasesTan, Wan-Ling ; Ng, Quan Sing ; Lim, Cindy; Tan, Eng Huat ; Toh, Chee Keong; Ang, Mei-Kim ; Kanesvaran, Ravindran ; Jain, Amit ; Tan, Daniel SW ; Lim, Darren Wan-Teck 
324-Dec-2018Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases (vol 18, 1198, 2018)Tan, Wan-Ling ; Ng, Quan Sing ; Lim, Cindy; Tan, Eng Huat ; Toh, Chee Keong; Ang, Mei-Kim ; Kanesvaran, Ravindran ; Jain, Amit ; Tan, Daniel SW ; Lim, Darren Wan-Teck 
41-Jun-2018Phase 1b Trial of Ficlatuzumab, a Humanized Hepatocyte Growth Factor Inhibitory Monoclonal Antibody, in Combination With Gefitinib in Asian Patients With NSCLCTan, Eng-Huat ; Lim, Wan-Teck ; Ahn, Myung-Ju; Ng, Quan-Sing ; Ahn, Jin Seok; Tan, Daniel Shao-Weng ; Sun, Jong-Mu; Han, May; Payumo, Francis C; Mckee, Krista; Yin, Wei; Credi, Marc; Agarwal, Shefali; Jac, Jaroslaw; Park, Keunchil